Suppr超能文献

滤泡性 Th 细胞与人类滤泡性淋巴瘤肿瘤细胞间的串扰促进肿瘤微环境中的免疫逃逸。

Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.

机构信息

Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

J Immunol. 2013 Jun 15;190(12):6681-93. doi: 10.4049/jimmunol.1201363. Epub 2013 May 17.

Abstract

The microenvironment of human follicular lymphoma (FL), an incurable B cell non-Hodgkin's lymphoma, is thought to play a major role in its pathogenesis and course. Microenvironmental cells of likely importance include follicular Th cells (TFH) and regulatory T cells (Tregs), and understanding their interactions with FL tumor cells is necessary to develop novel therapeutic strategies. We found that IL-4 and CD40L are expressed by intratumoral TFH and induce production of CCL17 and CCL22 by FL tumor cells. IL-4 alone induces only CCL17 but enhances stimulation by CD40L of both CCL17 and CCL22. Consistent with our in vitro results, mRNA transcripts of IL-4 correlated with CCL17, but not CCL22, in gene expression profiling studies of FL biopsies, whereas CD40L correlated with both CCL17 and CCL22. Tumor supernatants induced preferential migration of Tregs and IL-4-producing T cells rather than IFN-γ-producing T cells, and Abs to CCR4 significantly abrogated the migration of Tregs. Our results suggest that through two distinct mechanisms, intratumoral TFH induce production of CCL17 and CCL22 by FL tumor cells and facilitate active recruitment of Tregs and IL-4-producing T cells, which, in turn, may stimulate more chemokine production in a feed-forward cycle. Thus, TFH appear to play a major role in generating an immunosuppressive tumor microenvironment that promotes immune escape and tumor survival and growth. Our results provide novel insights into the cross talk among TFH, tumor cells, and Tregs in FL, and offer potential targets for development of therapeutic strategies to overcome immune evasion.

摘要

人类滤泡性淋巴瘤(FL)的微环境被认为在其发病机制和病程中起主要作用,FL 是一种不可治愈的 B 细胞非霍奇金淋巴瘤。可能重要的微环境细胞包括滤泡辅助性 T 细胞(TFH)和调节性 T 细胞(Treg),了解它们与 FL 肿瘤细胞的相互作用对于开发新的治疗策略是必要的。我们发现肿瘤内 TFH 表达 IL-4 和 CD40L,并诱导 FL 肿瘤细胞产生 CCL17 和 CCL22。IL-4 单独诱导仅 CCL17,但增强 CD40L 对 CCL17 和 CCL22 的刺激。与我们的体外结果一致,在 FL 活检的基因表达谱研究中,IL-4 的 mRNA 转录物与 CCL17 相关,但与 CCL22 不相关,而 CD40L 与 CCL17 和 CCL22 均相关。肿瘤上清液诱导 Treg 和产生 IL-4 的 T 细胞的优先迁移,而不是 IFN-γ 产生的 T 细胞,并且抗 CCR4 的 Abs 显著阻断了 Treg 的迁移。我们的结果表明,通过两种不同的机制,肿瘤内 TFH 诱导 FL 肿瘤细胞产生 CCL17 和 CCL22,并促进 Treg 和产生 IL-4 的 T 细胞的主动募集,这反过来又可能在正反馈循环中刺激更多的趋化因子产生。因此,TFH 似乎在产生促进免疫逃逸和肿瘤存活和生长的免疫抑制肿瘤微环境中起主要作用。我们的结果提供了 TFH、肿瘤细胞和 Treg 之间相互作用的新见解,并为开发克服免疫逃逸的治疗策略提供了潜在目标。

相似文献

4
Affinity-coupled CCL22 promotes positive selection in germinal centres.
Nature. 2021 Apr;592(7852):133-137. doi: 10.1038/s41586-021-03239-2. Epub 2021 Feb 17.
6
A high-throughput chemotaxis detection method for CCR4 T cell migration inhibition using image cytometry.
J Immunol Methods. 2020 Apr;479:112747. doi: 10.1016/j.jim.2020.112747. Epub 2020 Jan 17.
7
Mesenchymal stromal cells support the viability and differentiation of follicular lymphoma-infiltrating follicular helper T-cells.
PLoS One. 2014 May 16;9(5):e97597. doi: 10.1371/journal.pone.0097597. eCollection 2014.
9
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Clin Cancer Res. 2012 Apr 1;18(7):1925-35. doi: 10.1158/1078-0432.CCR-11-2941. Epub 2012 Feb 9.
10
EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22.
PLoS Pathog. 2022 Jan 13;18(1):e1010200. doi: 10.1371/journal.ppat.1010200. eCollection 2022 Jan.

引用本文的文献

1
STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma.
Leukemia. 2025 Apr;39(4):899-908. doi: 10.1038/s41375-025-02525-6. Epub 2025 Feb 5.
4
CCL17, CCL22 and their receptor CCR4 in hematologic malignancies.
Discov Oncol. 2024 Sep 6;15(1):412. doi: 10.1007/s12672-024-01210-x.
6
Follicular lymphoma regulatory T-cell origin and function.
Front Immunol. 2024 May 10;15:1391404. doi: 10.3389/fimmu.2024.1391404. eCollection 2024.
7
Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity.
NPJ Precis Oncol. 2024 May 20;8(1):108. doi: 10.1038/s41698-024-00595-w.
9
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Cell Stem Cell. 2024 Mar 7;31(3):410-420.e4. doi: 10.1016/j.stem.2024.01.012. Epub 2024 Feb 22.
10
Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas.
Front Oncol. 2023 Dec 22;13:1301437. doi: 10.3389/fonc.2023.1301437. eCollection 2023.

本文引用的文献

2
Foxp3+ follicular regulatory T cells control the germinal center response.
Nat Med. 2011 Jul 24;17(8):975-82. doi: 10.1038/nm.2425.
4
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
J Clin Oncol. 2011 Jul 10;29(20):2787-94. doi: 10.1200/JCO.2010.33.3005. Epub 2011 May 31.
7
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Leukemia. 2010 Dec;24(12):2080-9. doi: 10.1038/leu.2010.223. Epub 2010 Oct 14.
8
The elusive identity of T follicular helper cells.
Trends Immunol. 2010 Oct;31(10):377-83. doi: 10.1016/j.it.2010.07.001. Epub 2010 Aug 31.
10
CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.
Science. 2009 Nov 13;326(5955):986-91. doi: 10.1126/science.1172702. Epub 2009 Oct 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验